Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexlansoprazole vs double-dose omeprazole in non-responsive nonerosive gastroesophageal reflux disease
TCTR20160517003Phase 3Recruiting
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexlansoprazole, omeprazole in gastroesophageal reflux disease (GERD), sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Started Aug 2015; status: recruiting.
02
Drugs
dexlansoprazoleomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on TCTR20160517003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20160517003.